Paola Ferro
La Spezia, 19121, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score.
Journal: Diagnostics (Basel, Switzerland)
Published: August 06, 2021
Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis.
Journal: Journal of cancer research and clinical oncology
Published: July 29, 2020
Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma.
Journal: Cancer immunology, immunotherapy : CII
Published: July 01, 2020
Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma.
Journal: Anticancer research
Published: July 22, 2019
IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade.
Journal: Cellular & molecular immunology
Published: May 07, 2019
The Correlation of Serum Mesothelin Level With Pleural Thickness in Malignant Pleural Mesothelioma Makes it a Valuable Tool for Monitoring Tumor Progression.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 13, 2018
Use of Serum Mesothelin as an Indicator of Tumor Progression in Routine Clinical Practice of Malignant Pleural Mesothelioma Treatment.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 13, 2018
Evaluation of RET Gene Rearrangement by Fluorescence In Situ Hybridization in Malignant Mesothelioma.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 13, 2017
FISH Analysis of Crizotinib Target Genes ROS1/ALK/MET in Malignant Mesothelioma.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 15, 2017
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma.
Journal: Oncotarget
Published: January 31, 2017
Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma.
Journal: Anticancer research
Published: January 04, 2017
Last Updated: 09/26/2026